Disease Info Card

Fibrillary Astrocytoma

Information about Fibrillary Astrocytoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Fibrillary Astrocytoma

Most recent studies have shown that Fibrillary Astrocytoma shares some biological mechanisms with anaplastic-astrocytoma, astrocytoma, brain-neoplasms, cerebellar-neoplasms, ependymoma, epilepsy, ganglioglioma, glioblastoma, glioblastoma-multiforme, glioma, low-grade-glioma, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-recurrence-local, neoplasms, neoplasms-neuroepithelial, nervousness, oligodendroglioma, pilocytic-astrocytoma, tumor-progression.

Among the many pathways, these few ones have gauged particular interests from scientists studying Fibrillary Astrocytoma, and have been seen in publications frequently: Angiogenesis, Axon Guidance, Blood Coagulation, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Migration, Cell Proliferation, Coagulation, Dedifferentiation, Dna Repair, Localization, Locomotion, Methylation, Mitosis, Neuroblast Migration, Pathogenesis, Reverse Transcription, S Phase

Quite a number of genes have been found to play important roles in Fibrillary Astrocytoma, such as BCL2, CDKN1A, CDKN2A, CSF2, EGFR, ENO1, GFAP, JUN, LAMC2, MID1, MUC1, PCNA, PTEN, SGCA, SLIT2, TGM1, TP53, VEGFA, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.